Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 576

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 576
---
 subject to certain limited exceptions. The exercise price and number of shares of Common Stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of Common Stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. F-22

BELLEVUE LIFE SCIENCES ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2024 (UNAUDITED) NOTE 7 — STOCKHOLDERS’ DEFICIT (cont.) In addition, if (x) the Company issues additional shares of Common Stock or equity -linkedsecurities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $ 9.50per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s Board), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination (net of redemptions), and (z) the Market Value is below $ 9.50per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $ 16.50per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 165% of the Market Value. Equity Participation Shares The Company agreed to issue to the underwriter at the closing of the Initial Public Offering up to 34,500Equity Participation Shares, including over -allotment, which will be issued upon the completion of the Initial Business Combination. If the over -allotmentoption is not exercised in full, the Equity Participation Shares will be reduced pro rata. The Company complies with the requirements of ASC